{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreiaeyos4uxpoalifw4wck3ufvf742ocjn3scbab2empkjgirrtz5ca",
    "uri": "at://did:plc:5ka4qkui7nvjms7idhte2m4o/app.bsky.feed.post/3mnwlaq4vajz2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreihvkasvuqzyaovu7pds3hzpgjcclfk3fpg4adkgxcjzcr3wpwodlq"
    },
    "mimeType": "image/jpeg",
    "size": 59959
  },
  "path": "/2026/06/10/european-drug-pricing-most-favored-nation-impact/?utm_campaign=rss",
  "publishedAt": "2026-06-10T08:30:00.000Z",
  "site": "https://www.statnews.com",
  "tags": [
    "Pharma",
    "Politics",
    "biotechnology",
    "drug pricing",
    "Pharmaceuticals",
    "Policy",
    "STAT+"
  ],
  "textContent": "In Europe, two divergent paths are emerging as countries grapple with what to do about drug prices, affecting both pharma and patients — and testing the influence of the U.S.",
  "title": "STAT+: As the U.S. looks on, European countries feel growing pressure on drug prices",
  "updatedAt": "2026-06-09T14:39:38.000Z"
}